https://www.news-medical.net/news/20221109/Collaboration-aims-to-develop-new-medicines-for-neurodegenerative-diseases.aspx
0
0
50 words
0
Comments
The ALBORADA Drug Discovery Institute (ADDI) today (Tuesday 8 November) announced that it will collaborate with pharmaceutical company YD Global Life Science (YDGLS) to develop inhibitors of the unfolded protein response for the treatment of the diseases that…
You are the first to view
Create an account or login to join the discussion